Skip to main content
Top
Published in: Endocrine 1/2014

01-09-2014 | Original Article

Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction

Authors: Marta Ragonese, Angela Alibrandi, Gianluca Di Bella, Ignazio Salamone, Soraya Puglisi, Oana Ruxandra Cotta, Maria Luisa Torre, Francesco Ferrau, Rosaria Maddalena Ruggeri, Francesco Trimarchi, Salvatore Cannavo

Published in: Endocrine | Issue 1/2014

Login to get access

Abstract

Prediction of ischemic cardiovascular events (ICE) in acromegalic patients stratified accordingly with Framingham (FS) and Agatston score (AS). 32 patients with active (group A 0) and 20 with controlled (group B 0) acromegaly have been enrolled. During the 5-year follow-up, 19 out of 32 patients in group A 0 reached disease control. At entry, FS and AS, by an eight-slice MDCT scanner, were calculated in all patients. ICE were diagnosed by autopsy, if lethal, and by electrocardiography and/or echocardiography, if non-lethal. Overall, 9.6 % of patients died for lethal ICE. AS >400, but not high FS at entry, was associated with increased risk of lethal ICE. Lethal ICE had occurred in two patients of group A 0 and three of group B 0 (p NS), while a non-lethal ICE had occurred in two cases of the former and in other two of the latter group (p NS). Either FS or AS was correlated with the risk for ICE overall (p < 0.02), but only AS correlated with that of lethal ICE (p < 0.0003). Survival analysis demonstrated reduced life expectancy in patients with high FS (p < 0.02). In acromegalics, AS >400 is associated with increased risk of lethal ICE, while high FS is associated with reduced life expectancy, regardless of disease control.
Literature
2.
go back to reference C. Berg, S. Petersenn, H. Lahner, B.L. Herrmann, M. Buchfelder, M. Droste, G.K. Stalla, C.J. Strasburger, U. Roggenbuck, N. Lehmann, S. Moebus, K. Jöckel, S. Möhlenkamp, R. Erbel, B. Saller, K. Mann, Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J. Clin. Endocrinol. Metab. 95, 3648–3656 (2010)PubMedCrossRef C. Berg, S. Petersenn, H. Lahner, B.L. Herrmann, M. Buchfelder, M. Droste, G.K. Stalla, C.J. Strasburger, U. Roggenbuck, N. Lehmann, S. Moebus, K. Jöckel, S. Möhlenkamp, R. Erbel, B. Saller, K. Mann, Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control. J. Clin. Endocrinol. Metab. 95, 3648–3656 (2010)PubMedCrossRef
3.
go back to reference I.M. Holdaway, R.C. Rajasoorya, G.D. Gamble, Factors influencing mortality in acromegaly. J. Clin. Endocrinol. Metab. 89, 667–674 (2004)PubMedCrossRef I.M. Holdaway, R.C. Rajasoorya, G.D. Gamble, Factors influencing mortality in acromegaly. J. Clin. Endocrinol. Metab. 89, 667–674 (2004)PubMedCrossRef
4.
go back to reference S. Cannavo, B. Almoto, G. Cavalli, S. Squadrito, G. Romanello, M.T. Vigo, F. Fiumara, S. Benvenga, F. Trimarchi, Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. J. Clin. Endocrinol. Metab. 91, 3766–3772 (2006)PubMedCrossRef S. Cannavo, B. Almoto, G. Cavalli, S. Squadrito, G. Romanello, M.T. Vigo, F. Fiumara, S. Benvenga, F. Trimarchi, Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. J. Clin. Endocrinol. Metab. 91, 3766–3772 (2006)PubMedCrossRef
5.
go back to reference P. Schoenhagen, A.E. Stillman, S.S. Halliburton, R.D. White, CT of the heart: principles, advances, clinical uses. Clevel. Clin. J. Med. 72, 88–89 (2005)CrossRef P. Schoenhagen, A.E. Stillman, S.S. Halliburton, R.D. White, CT of the heart: principles, advances, clinical uses. Clevel. Clin. J. Med. 72, 88–89 (2005)CrossRef
6.
go back to reference F. Bogazzi, L. Battolla, C. Spinelli, G. Rossi, S. Gavioli, V. Di Bello, C. Cosci, C. Sardella, D. Volterrani, E. Talini, P. Pepe, F. Falaschi, G. Mariani, E. Martino, Risk factors for development os coronary heart disease in patients with acromegaly: a 5-year prospective study. J. Clin. Endocrinol. Metab. 92, 4271–4277 (2007)PubMedCrossRef F. Bogazzi, L. Battolla, C. Spinelli, G. Rossi, S. Gavioli, V. Di Bello, C. Cosci, C. Sardella, D. Volterrani, E. Talini, P. Pepe, F. Falaschi, G. Mariani, E. Martino, Risk factors for development os coronary heart disease in patients with acromegaly: a 5-year prospective study. J. Clin. Endocrinol. Metab. 92, 4271–4277 (2007)PubMedCrossRef
7.
go back to reference H. Akutsu, J. Kreutzer, G. Wasmeier, D. Ropers, C. Rost, M. Möhlig, H. Wallaschofski, M. Buchfelder, C. Schöfl, Acromegaly per se does not increase the risk for coronary artery disease. Eur. J. Endocrinol. 162, 879–886 (2010)PubMedCrossRef H. Akutsu, J. Kreutzer, G. Wasmeier, D. Ropers, C. Rost, M. Möhlig, H. Wallaschofski, M. Buchfelder, C. Schöfl, Acromegaly per se does not increase the risk for coronary artery disease. Eur. J. Endocrinol. 162, 879–886 (2010)PubMedCrossRef
8.
go back to reference B.L. Herrmann, M. Severing, A. Schmermund, C. Berg, T. Budde, R. Erbel, K. Mann, Impact of disease duration on coronary calcification in patients with acromegaly. Exp. Clin. Endocrinol. Diabetes 117, 417–422 (2009)PubMedCrossRef B.L. Herrmann, M. Severing, A. Schmermund, C. Berg, T. Budde, R. Erbel, K. Mann, Impact of disease duration on coronary calcification in patients with acromegaly. Exp. Clin. Endocrinol. Diabetes 117, 417–422 (2009)PubMedCrossRef
9.
go back to reference A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000)PubMed A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000)PubMed
10.
go back to reference S. Melmed, F. Casanueva, F. Cavagnini, P. Chanson, L.A. Frohman, R. Gaillard, E. Ghigo, K. Ho, P. Jaquet, D. Kleinberg, S. Lamberts, E. Laws, G. Lombardi, M.C. Sheppard, M. Thorner, M.L. Vance, J.A.H. Wass, A. Giustina, Consensus statement: medical management of acromegaly. Eur. J. Endocrinol. 153, 737–740 (2005)PubMedCrossRef S. Melmed, F. Casanueva, F. Cavagnini, P. Chanson, L.A. Frohman, R. Gaillard, E. Ghigo, K. Ho, P. Jaquet, D. Kleinberg, S. Lamberts, E. Laws, G. Lombardi, M.C. Sheppard, M. Thorner, M.L. Vance, J.A.H. Wass, A. Giustina, Consensus statement: medical management of acromegaly. Eur. J. Endocrinol. 153, 737–740 (2005)PubMedCrossRef
11.
go back to reference P. Greenland, R.O. Bonow, B.H. Brundage, M.J. Budoff, M.J. Eisemberg, S.M. Grundy, M.S. Lauer, W.S. Post, P. Raggi, R.F. Redberg, G.P. Rodgers, L.J. Shaw, A.J. Taylor, W.S. Weintraub, American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography); Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography.: ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patient with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 49, 378–402 (2007)PubMedCrossRef P. Greenland, R.O. Bonow, B.H. Brundage, M.J. Budoff, M.J. Eisemberg, S.M. Grundy, M.S. Lauer, W.S. Post, P. Raggi, R.F. Redberg, G.P. Rodgers, L.J. Shaw, A.J. Taylor, W.S. Weintraub, American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography); Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography.: ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patient with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 49, 378–402 (2007)PubMedCrossRef
12.
go back to reference Y. Arad, K.J. Goodman, M. Roth, D. Newstein, A.D. Guerci, Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J. Am. Coll. Cardiol. 46, 158–165 (2005)PubMedCrossRef Y. Arad, K.J. Goodman, M. Roth, D. Newstein, A.D. Guerci, Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J. Am. Coll. Cardiol. 46, 158–165 (2005)PubMedCrossRef
13.
go back to reference S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer, L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith, N.J. Stone, Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Arterioscler. Thromb. Vasc. Biol. 24, 149–161 (2004)CrossRef S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer, L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith, N.J. Stone, Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Arterioscler. Thromb. Vasc. Biol. 24, 149–161 (2004)CrossRef
14.
go back to reference P.Y. Che, P.M. Popovich, Correlation: parametric and nonparametric measures (Sage Publications, Thousand Oaks, 2002), pp. 95–97 P.Y. Che, P.M. Popovich, Correlation: parametric and nonparametric measures (Sage Publications, Thousand Oaks, 2002), pp. 95–97
15.
go back to reference D.G. Kleimbaum, M. Klein, Logistic regression. A self-learning text, 2nd edn. (Springer, New York, 2002) D.G. Kleimbaum, M. Klein, Logistic regression. A self-learning text, 2nd edn. (Springer, New York, 2002)
16.
go back to reference P.K.A. Andersen, R.D. Gill, Cox’s regression model for counting processes: a large sample study. Ann. Stat. 10, 1100–1120 (1982)CrossRef P.K.A. Andersen, R.D. Gill, Cox’s regression model for counting processes: a large sample study. Ann. Stat. 10, 1100–1120 (1982)CrossRef
18.
go back to reference A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complication of acromegaly: epidemiology, pathogenesis and management. Endocr Rev 25, 102–152 (2004)PubMedCrossRef A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complication of acromegaly: epidemiology, pathogenesis and management. Endocr Rev 25, 102–152 (2004)PubMedCrossRef
19.
go back to reference S. Cannavò, F. Ferraù, M. Ragonese, L. Curtò, M.L. Torre, M. Magistri, A. Marchese, A. Alibrandi, F. Trimarchi, Increased prevalence of acromegaly in a highly polluted area. Eur. J. Endocrinol. 163, 509–513 (2010)PubMedCrossRef S. Cannavò, F. Ferraù, M. Ragonese, L. Curtò, M.L. Torre, M. Magistri, A. Marchese, A. Alibrandi, F. Trimarchi, Increased prevalence of acromegaly in a highly polluted area. Eur. J. Endocrinol. 163, 509–513 (2010)PubMedCrossRef
20.
go back to reference M. Bex, R. Abs, G. T’Sjoen, J. Mockel, B. Velkeniers, K. Muermans, D. Maiter, AcroBel—the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects. Eur. J. Endocrinol. 157, 399–409 (2007)PubMedCrossRef M. Bex, R. Abs, G. T’Sjoen, J. Mockel, B. Velkeniers, K. Muermans, D. Maiter, AcroBel—the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects. Eur. J. Endocrinol. 157, 399–409 (2007)PubMedCrossRef
21.
go back to reference R. Kauppinen-Makelin, T. Sane, A. Reunanen, M.J. Valimaki, L. Niskanen, H. Markkanen, E. Loyttyniemi, T. Ebeling, P. Jaatinen, H. Laine, P. Nuutila, P. Salmela, J. Salmi, U.H. Stenman, J. Viikari, E. Voutilainen, A nationwide survey of mortality in acromegaly. J. Clin. Endocrinol. Metab. 90, 4081–4086 (2005)PubMedCrossRef R. Kauppinen-Makelin, T. Sane, A. Reunanen, M.J. Valimaki, L. Niskanen, H. Markkanen, E. Loyttyniemi, T. Ebeling, P. Jaatinen, H. Laine, P. Nuutila, P. Salmela, J. Salmi, U.H. Stenman, J. Viikari, E. Voutilainen, A nationwide survey of mortality in acromegaly. J. Clin. Endocrinol. Metab. 90, 4081–4086 (2005)PubMedCrossRef
23.
go back to reference Buiatti E, Barchielli A, Balzi D, Pasqua A., Puglia M.: Registro regionale toscano dell’infarto miocardico acuto [Tosc-AMI]. Primo rapporto: incidenza e prognosi dal 1997 al 2002. Documenti ARS Toscana, Osservatorio di Epidemiologia, Documento n. 19, 2005 available on www.arsanita.toscana.it Buiatti E, Barchielli A, Balzi D, Pasqua A., Puglia M.: Registro regionale toscano dell’infarto miocardico acuto [Tosc-AMI]. Primo rapporto: incidenza e prognosi dal 1997 al 2002. Documenti ARS Toscana, Osservatorio di Epidemiologia, Documento n. 19, 2005 available on www.​arsanita.​toscana.​it
24.
go back to reference J.T. Lie, S.J. Grossman, Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am. Heart J. 100, 41–52 (1980)PubMedCrossRef J.T. Lie, S.J. Grossman, Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am. Heart J. 100, 41–52 (1980)PubMedCrossRef
25.
go back to reference P. Greenland, R.O. Bonow, B.H. Brundage, M.J. Budoff, M.J. Eisemberg, S.M. Grundy, M.S. Lauer, W.S. Post, P. Raggi, R.F. Redberg, G.P. Rodgers, L.J. Shaw, A.J. Taylor, W.S. Weintraub, R.A. Harrington, J. Abrams, J.L. Anderson, E.R. Bates, C.L. Grines, M.A. Hlatky, R.C. Lichtenberg, J.R. Lindner, G.M. Pohost, R.S. Schofield, S.J. Shubrooks Jr, J.H. Stein, C.M. Tracy, R.A. Vogel, D.J. Wesley, ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain. Circulation 115, 402–426 (2007)PubMedCrossRef P. Greenland, R.O. Bonow, B.H. Brundage, M.J. Budoff, M.J. Eisemberg, S.M. Grundy, M.S. Lauer, W.S. Post, P. Raggi, R.F. Redberg, G.P. Rodgers, L.J. Shaw, A.J. Taylor, W.S. Weintraub, R.A. Harrington, J. Abrams, J.L. Anderson, E.R. Bates, C.L. Grines, M.A. Hlatky, R.C. Lichtenberg, J.R. Lindner, G.M. Pohost, R.S. Schofield, S.J. Shubrooks Jr, J.H. Stein, C.M. Tracy, R.A. Vogel, D.J. Wesley, ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain. Circulation 115, 402–426 (2007)PubMedCrossRef
26.
go back to reference S. Cannavò, S. Squadrito, L. Curtò, B. Almoto, A. Vieni, F. Trimarchi, Results of a two-year treatment with slow release Lanreotide in acromegaly. Horm. Metab. Res. 32, 224–229 (2000)PubMedCrossRef S. Cannavò, S. Squadrito, L. Curtò, B. Almoto, A. Vieni, F. Trimarchi, Results of a two-year treatment with slow release Lanreotide in acromegaly. Horm. Metab. Res. 32, 224–229 (2000)PubMedCrossRef
27.
go back to reference S. Cannavò, S. Squadrito, L. Curtò, B. Almoto, F. Trimarchi, Effectiveness of slow-release Lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma. Horm. Metab. Res. 33, 618–624 (2001)PubMedCrossRef S. Cannavò, S. Squadrito, L. Curtò, B. Almoto, F. Trimarchi, Effectiveness of slow-release Lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma. Horm. Metab. Res. 33, 618–624 (2001)PubMedCrossRef
28.
go back to reference A. Colao, G. Arnaldi, P. Beck-Peccoz, S. Cannavò, R. Cozzi, E. degli Uberti, L. De Marinis, E. De Menis, D. Ferone, V. Gasco, A. Giustina, S. Grottoli, G. Lombardi, P. Maffei, E. Martino, F. Minuto, R. Pivonello, E. Ghigo, Pegvisomant in acromegaly: why, when, how. J. Endocrinol. Invest. 30, 693–699 (2007)PubMedCrossRef A. Colao, G. Arnaldi, P. Beck-Peccoz, S. Cannavò, R. Cozzi, E. degli Uberti, L. De Marinis, E. De Menis, D. Ferone, V. Gasco, A. Giustina, S. Grottoli, G. Lombardi, P. Maffei, E. Martino, F. Minuto, R. Pivonello, E. Ghigo, Pegvisomant in acromegaly: why, when, how. J. Endocrinol. Invest. 30, 693–699 (2007)PubMedCrossRef
30.
go back to reference G. Mazziotti, T. Porcelli, F. Bogazzi, G. Bugari, S. Cannavò, A. Colao, R. Cozzi, L. De Marinis, E. degli Uberti, S. Grottoli, F. Minuto, M. Montini, M. Spinello, A. Giustina, Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy. Eur. J. Endocrinol. 164, 341–347 (2011)PubMedCrossRef G. Mazziotti, T. Porcelli, F. Bogazzi, G. Bugari, S. Cannavò, A. Colao, R. Cozzi, L. De Marinis, E. degli Uberti, S. Grottoli, F. Minuto, M. Montini, M. Spinello, A. Giustina, Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy. Eur. J. Endocrinol. 164, 341–347 (2011)PubMedCrossRef
31.
go back to reference I.M. Holdaway, M.J. Bolland, G.D. Gamble, A metanalysis of the effect of lowering serum levels of GH and IGF-1 on mortality in acromegaly. Eur. J. Endocrinol. 159, 89–95 (2008)PubMedCrossRef I.M. Holdaway, M.J. Bolland, G.D. Gamble, A metanalysis of the effect of lowering serum levels of GH and IGF-1 on mortality in acromegaly. Eur. J. Endocrinol. 159, 89–95 (2008)PubMedCrossRef
Metadata
Title
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction
Authors
Marta Ragonese
Angela Alibrandi
Gianluca Di Bella
Ignazio Salamone
Soraya Puglisi
Oana Ruxandra Cotta
Maria Luisa Torre
Francesco Ferrau
Rosaria Maddalena Ruggeri
Francesco Trimarchi
Salvatore Cannavo
Publication date
01-09-2014
Publisher
Springer US
Published in
Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0115-8

Other articles of this Issue 1/2014

Endocrine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.